BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2145066)

  • 1. Antimyoclonic effect of MK-801: a possible role for NMDA receptors in developmental myoclonus of the neonatal rat.
    Pranzatelli MR
    Clin Neuropharmacol; 1990 Aug; 13(4):329-38. PubMed ID: 2145066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
    Zhang XX; Bunney BS; Shi WX
    Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus.
    Tai KK; Truong DD
    Brain Res; 2010 Jul; 1343():194-8. PubMed ID: 20434435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of antiepileptic and antimyoclonic drugs.
    Pranzatelli MR; Nadi NS
    Adv Neurol; 1995; 67():329-60. PubMed ID: 8848979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME; Lasley SM
    Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency-dependent inhibition in the dentate gyrus is attenuated by the NMDA receptor blocker MK-801 at doses that do not yet affect long-term potentiation.
    Rosenblum K; Maroun M; Richter-Levin G
    Hippocampus; 1999; 9(5):491-4. PubMed ID: 10560918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of MK-801-induced behavior as a putative rat model of psychosis.
    Andiné P; Widermark N; Axelsson R; Nyberg G; Olofsson U; Mårtensson E; Sandberg M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1393-408. PubMed ID: 10454519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration.
    Thomas JD; Fleming And SL; Riley EP
    Alcohol Clin Exp Res; 2001 May; 25(5):764-73. PubMed ID: 11371726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
    Zhong J; Gribkoff VK; Molinoff PB
    Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM; Solís JM
    Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ethanol state-dependent learning by dorsal hippocampal NMDA receptors in mice.
    Rezayof A; Sharifi K; Zarrindast MR; Rassouli Y
    Alcohol; 2008 Dec; 42(8):667-74. PubMed ID: 18774674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of NMDA receptors in thiopental-induced loss of righting reflex, antinociception and anticonvulsion effects in mice.
    Ge ZJ; Zhang LC; Zeng YM; Da TJ; Wang JK; Cui GX; Tan YF; Zhao YP; Liu GJ
    Pharmacology; 2007; 80(2-3):127-33. PubMed ID: 17534122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
    van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.